Defining progression of ovarian carcinoma during follow-up according to CA 125: A North Thames Ovary Group study
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/7/4/361/475429/7-4-361.pdf
Reference7 articles.
1. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer;Bast;N Engl J Med,1983
2. Tumour markers in the management of patients with ovarian cancer;Tuxen;Cancer Treat Rev,1995
3. The role of CA 125 as a tumour marker in ovarian carcinoma;Krebs;Obstet Gynecol,1986
4. The role of CA 125 in the early diagnosis of progressive disease in ovarian cancer;Van der Burg;Ann Oncol,1990
5. Tumour markers;Rustin;Ann Oncol,1993
Cited by 204 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Preoperative and pre-chemotherapy CA-125 levels in high-risk early-stage ovarian cancer – An NRG/GOG study;Gynecologic Oncology;2024-02
2. Poor Concordance Between Cancer Antigen-125 and RECIST Assessment for Progression in Patients With Platinum-Sensitive Relapsed Ovarian Cancer on Maintenance Therapy With a Poly(ADP-ribose) Polymerase Inhibitor;Journal of Clinical Oncology;2024-01-12
3. An increase of serum CA-125 to two times of nadir level strongly predicts the image-identified recurrence of serous ovarian cancer;2024-01-10
4. Discordance between GCIG CA-125 progression and RECIST progression in the CALYPSO trial of patients with platinum-sensitive recurrent ovarian cancer;British Journal of Cancer;2023-12-14
5. Pegylated liposomal doxorubicin for relapsed epithelial ovarian cancer;Cochrane Database of Systematic Reviews;2023-07-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3